Abstract
Platelets are unique cells of human body: they lack nucleus, are rather small in size (1–2 μm) and involved in several physiological functions, including hemostasis, immunity and angiogenesis. Platelets play a key role in the initiation of thrombosis upon injury of the blood vessels of the arterial bed, in which blood flows with high shear rates are observed. According to the generally accepted concepts, the reaction of platelets to endothelial injury at local shear rates of more than 1000 s–1 is the primary binding of the GPIb-IX-V receptor complex glycoproteins with von Willebrand factor, a large multimeric blood protein which can specifically bind to collagen fibers. For further performance of their functions, and first of all, for stable attachment to the injured surface, platelet has to be activated. There are more than ten types of receptors on the platelet membrane, which trigger several cascades of intracellular signaling that leads to the restructuring of the cytoskeleton, granule secretion and activation of integrins, which provide the ability of platelets to strong adhesion and aggregation. This review is focused on the biophysical aspects of the interaction of transmembrane glycoproteins and integrins with extracellular ligands, as well as modern ideas about the mechanisms of platelet activation that is necessary to stabilize their primary adhesion and aggregation.
Similar content being viewed by others
REFERENCES
Esmon C. 2009. Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev. 23, 225–229.
Nieswandt B.,Watson S. 2003. Platelet-collagen interaction: Is GPVI the central receptor? Blood. 102, 449–461.
Best D., Senis Y., Jarvis G., Eagleton H., Roberts D., Saito T., Jung S., Moroi M., Harrison P., Green F., Watson S. 2003. GPVI levels in platelets: Relationship to platelet function at high shear. Blood. 102, 2811–2818.
Herr A., Farndale R. 2009. Structural insights into the interactions between platelet receptors and fibrillar collagen. J. Biol. Chem. 284, 19781–19785.
Jung S., Takemura Y., Imamura Y., Hayashi T., Adachi E., Moroi M. 2009. Collagen-type specificity of glycoprotein VI as a determinant of platelet adhesion. Platelets. 19, 32–42.
Savage B., Saldívar E., Ruggeri Z. 1996. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 84, 289–297.
Miura Y., Takahashi T., Jung S., Moroi M. 2002. Analysis of the interaction of platelet collagen receptor glycoprotein VI (GPVI) with collagen: A dimeric form of GPVI, but not the monomeric form, shows affinity to fibrous collagen. J. Biol. Chem. 277, 46197–46204.
Varga-Szabo D., Pleines I., Nieswandt B. 2008. Cell adhesion mechanisms in platelets. Arterioscler. Thromb. Vasc. Biol. 28, 403–412.
Colace T., Tormoen G., McCarty O., Diamond S. 2013. Microfluidics and coagulation biology. Annu. Rev. Biomed. Eng. 15, 283–303.
Jackson S. 2007. The growing complexity of platelet aggregation. Blood. 109, 5087–5095.
Mody N., King M. 2008. Platelet adhesive dynamics. Part I: Characterization of platelet hydrodynamic collisions and wall effects. Biophys. J. 95, 2539–2555.
Kim J., Zhang C., Zhang X., Springer T. 2010. A mechanically stabilized receptor–ligand flex-bond important in the vasculature. Nature. 466, 992–995.
Westein E., van der Meer A., Kuijpers M., Frimat J., van den Berg A., Heemskerk J. 2013. Atherosclerotic geometries exacerbate pathological thrombus formation poststenosis in a von Willebrand factor-dependent manner. Proc. Natl. Acad. Sci. USA. 110, 1357–1362.
Singh I., Themistou E., Porcar L., Neelamegham S. 2009. Fluid shear induces conformation change in human blood protein von Willebrand factor in solution. Biophys. J. 96, 2313–2320.
Zhang X., Halvorsen K., Zhang C., Wong W., Springer T. 2009. Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. Science. 324, 1330–1334.
Schneider S., Nuschele S., Wixforth A., Gorzelanny C., Alexander-Katz A., Netz R., Schneider M. 2007. Shear-induced unfolding triggers adhesion of von Willebrand factor fibers. Proc. Natl. Acad. Sci. USA. 104, 7899–7903.
Springer T. 2014. Von Willebrand factor, Jedi knight of the bloodstream. Blood. 124, 1412–1425.
Maxwell M., Westein E., Nesbitt W., Giuliano S., Dopheide S., Jackson S. 2007. Identification of a 2‑stage platelet aggregation process mediating shear-dependent thrombus formation. Blood. 109, 566–576.
Arya M., Anvari B., Romo G., Cruz M., Dong J., McIntire L., Moake J., López J. 2002. Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: Studies using optical tweezers. Blood. 99, 3971–3977.
Nesbitt W., Westein E., Tovar-Lopez F., Tolouei E., Mitchell A., Fu J., Carberry J., Fouras A., Jackson S. 2009. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat. Med. 15, 665–673.
Baldauf C., Schneppenheim R., Stacklies W., Obser T., Pieconka A., Schneppenheim S., Budde U., Zhou J., Gräter F. 2009. Shear-induced unfolding activates von Willebrand factor A2 domain for proteolysis. J. Thromb. Haemost. 7, 2096–2105.
Goldman A., Cox R., Brenner H. 1967. Slow viscous motion of a sphere parallel to a plane wall-I Motion through a quiescent fluid. Chem. Eng. Sci. 22, 637–651.
Goto S., Salomon D., Ikeda Y., Ruggeri Z. 1995. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J. Biol. Chem. 270, 23352–23361.
Miura S., Li C., Cao Z., Wang H., Wardell M., Sadler J. 2000. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ib. J. Biol. Chem. 275, 7539–7546.
Li Z., Delaney M., O’Brien K., Du X. 2010. Signaling during platelet adhesion and activation. Arterioscler. Thromb. Vasc. Biol. 30, 2341–2349.
Varga-Szabo D., Braun A., Nieswandt B. 2009. Calcium signaling in platelets.Thromb. Haemost. 7, 1057–1066.
Heemskerk J., Mattheij N., Cosemans J. 2013. Platelet-based coagulation: Different populations, different functions. J. Thromb. Haemost. 11, 2–16.
Versteeg H., Heemskerk J., Levi M., Reitsma P. 2013. New fundamentals in hemostasis. Physiol. Rev. 93, 327–358.
Sveshnikova A., Ataullakhanov F., Panteleev M. 2015. Compartmentalized calcium signaling triggers subpopulation formation upon platelet activation through PAR1. Mol. Biosyst. 11, 1052–1060.
Shakhidzhanov S., Shaturny V., Panteleev M., Sveshnikova A. 2015. Modulation and pre-amplification of PAR1 signaling by ADP acting via the P2Y12 receptor during platelet subpopulation formation. Biochim. Biophys. Acta – Gen. Subj. 1850, 2518–2529.
Obydennyi S., Sveshnikova A., Ataullakhanov F., Panteleev M. 2015. Dynamics of calcium spiking, mitochondrial collapse and phosphatidylserine exposure in single platelets during activation. J. Thromb. Haemost. 13, 649.
Kroll M., Hellums J., McIntire L., Schafer A., Moake J. 1996. Platelets and shear stress. Blood. 88, 1525–1541.
Andrews R., Arthur J., Gardiner E. 2014. Targeting GPVI as a novel antithrombotic strategy. J. Blood Med. 5, 59–68.
Sullam P. 1998. Physical proximity and functional interplay of the glycoprotein Ib–IX–V complex and the Fc receptor Fcgamma RIIA on the platelet plasma membrane. J. Biol. Chem. 273, 5331–5336.
Berndt M., Metharom P., Andrews R. 2014. Primary haemostasis: Newer insights. Haemophilia. 20, 15–22.
Bryckaert M., Rosa J., Denis C., Lenting P. 2015. Of von Willebrand factor and platelets. Cell. Mol. Life Sci. 72, 307–326.
Gu M. 1999. Analysis of the roles of 14-3-3 in the platelet glycoprotein Ib-IX-mediated activation of integrin alphaiibbeta3 using a reconstituted mammalian cell expression model. J. Cell Biol. 147, 1085–1096.
Riba R., Oberprieler N., Roberts W., Naseem K. 2006. Von Willebrand factor activates endothelial nitric oxide synthase in blood platelets by a glycoprotein Ib-dependent mechanism. J. Thromb. Haemost. 4, 2636–2644.
Kasirer-Friede A., Moran B., Nagrampa-Orje J., Swanson K., Ruggeri Z., Schraven B., Neel B., Koretzky G., Shattil S. 2007. ADAP is required for normal alphaIIbbeta3 activation by VWF/GP Ib-IX-V and other agonists. Blood. 109, 1018–1025.
Yin H., Liu J., Li Z., Berndt M., Lowell C., Du X. 2008. Src family tyrosine kinase Lyn mediates VWF/GPIb-IX-induced platelet activation via the cGMP signaling pathway. Blood. 112, 1139–1146.
Kasirer-Friede A., Cozzi M., Mazzucato M., De Marco L., Ruggeri Z., Shattil S. 2004. Signaling through GP Ib-IX-V activates alpha IIb beta 3 independently of other receptors. Blood. 103, 3403–3411.
Nesbitt W., Kulkarni S., Giuliano S., Goncalves I., Dopheide S., Yap C., Harper I., Salem H. H., Jackson S. 2002. Distinct glycoprotein Ib/V/IX and integrin alpha II beta 3-dependent calcium signals cooperatively regulate platelet adhesion under flow. J. Biol. Chem. 277, 2965–2972.
Ozaki Y., Asazuma N., Suzuki-Inoue K., Berndt M. 2005. Platelet GPIb-IX-V-dependent signaling. J. Thromb. Haemost. 3, 1745–1751.
Nalayanda D., Kalukanimuttam M., Schmidtke D. 2007. Micropatterned surfaces for controlling cell adhesion and rolling under flow. Biomed. Microdevices. 9, 207–214.
Yuan Y., Kulkarni S., Ulsemer P., Cranmer S., Yap C., Nesbitt W., Harper I., Mistry N., Dopheide S., Hughan S., Williamson D., de la Salle C., Salem H., Lanza F., Jackson S. 1999. The von Willebrand factor-glycoprotein Ib/V/IX interaction induces actin polymerization and cytoskeletal reorganization in rolling platelets and glycoprotein Ib/V/IX-transfected cells. J. Biol. Chem. 274, 36241–36251.
Nieswandt B., Varga-Szabo D., Elvers M. 2009. Integrins in platelet activation. J. Thromb. Haemost. 206–209.
Grüner S., Prostredna M., Schulte V., Krieg T., Eckes B., Brakebusch C., Nieswandt B. 2003. Multiple integrin-ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo. Blood. 102, 4021–4027.
Moser M., Nieswandt B., Ussar S., Pozgajova M., Fässler R. 2008. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat. Med. 14, 325–330.
Nieswandt B., Moser M., Pleines I., Varga-Szabo D., Monkley S., Critchley D., Fässler R. 2007. Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo. J. Exp. Med. 204, 3113–3118.
Cifuni S., Wagner D., Bergmeier W. 2008. CalDAG-GEFI and protein kinase C represent alternative pathways leading to activation of integrin alphaIIbbeta3 in platelets. Blood. 112, 1696–1703.
Manganaro D., Consonni A., Guidetti G., Canobbio I., Visconte C., Kim S., Okigaki M., Falasca M., Hirsch E., Kunapuli S., Torti M. 2015. Activation of phosphatidylinositol 3-kinase β by the platelet collagen receptors integrin α2β1 and GPVI: The role of Pyk2 and c-Cbl. Biochim. Biophys. Acta. 1853, 1879–1888.
Inoue O., Suzuki-Inoue K., Dean W., Frampton J., Watson S. 2003. Integrin alpha2beta1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCgamma2. J. Cell Biol. 160, 769–780.
Chen H., Kahn M. 2003. Reciprocal signaling by integrin and nonintegrin receptors during collagen activation of platelets. Mol. Cell. Biol. 23, 4764–4777.
Smith C., Estavillo D., Emsley J., Bankston L., Liddington R., Cruz M. 2000. Mapping the collagen-binding site in the I domain of the glycoprotein Ia/IIa (Integrin 2 1). J. Biol. Chem. 275, 4205–4209.
Nieswandt B., Brakebusch C., Bergmeier W., Schulte V., Bouvard D., Mokhtari-Nejad R., Lindhout T., Heemskerk J., Zirngibl H., Fässler R. 2001. Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen. EMBO J. 20, 2120–2130.
Clemetson J., Polgar J., Magnenat E., Wells T., Clemetson K. 1999. The platelet collagen receptor glycoprotein VI Is a member of the immunoglobulin superfamily closely related to Fc R and the natural killer receptors. J. Biol. Chem. 274, 29019–29024.
Tsuji M., Ezumi Y., Arai M., Takayama H. 1997. A novel association of Fc receptor γ-chain with glycoprotein VI and their co-expression as a collagen receptor in human platelets. J. Biol. Chem. 272, 23528–23531.
Bergmeier W., Stefanini L. 2013. Platelet ITAM signaling. Curr. Opin. Hematol. 20, 445–450.
Suzuki-Inoue K., Tulasne D., Shen Y., Bori-Sanz T., Inoue O., Jung S., Moroi M., Andrews R., Berndt M., Watson S. 2002. Association of Fyn and Lyn with the proline-rich domain of glycoprotein VI regulates intracellular signaling. J. Biol. Chem. 277, 21561–21566.
Gibbins J., Okuma M., Farndale R., Barnes M., Watson S. 1997. Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor γ-chain. FEBS Lett. 413, 255–259.
Watson S., Herbert J., Pollitt A. 2010. GPVI and CLEC-2 in hemostasis and vascular integrity. J. Thromb. Haemost. 8, 1456–1467.
Schmaier A., Zou Z., Kazlauskas A., Emert-Sedlak L., Fong K., Neeves K., Maloney S., Diamond S. L., Kunapuli S., Ware J., Brass L., Smithgall T., Saksela K., Kahn M. 2009. Molecular priming of Lyn by GPVI enables an immune receptor to adopt a hemostatic role. Proc. Natl. Acad. Sci. USA. 106, 21167–21172.
Mangin P., Nonne C., Eckly A., Ohlmann P., Freund M., Nieswandt B., Cazenave J., Gachet C., Lanza F. 2003. A PLCγ2-independent platelet collagen aggregation requiring functional association of GPVI and integrin α2β1. FEBS Lett. 542, 53–59.
Andrews R., Suzuki-Inoue K., Shen Y., Tulasne D., Watson S., Berndt M. 2002. Interaction of calmodulin with the cytoplasmic domain of platelet glycoprotein VI. Blood. 99, 4219–4221.
Stephens G., Yan Y., Jandrot-Perrus M., Villeval J., Clemetson K., Phillips D. 2005. Platelet activation induces metalloproteinase-dependent GP VI cleavage to down-regulate platelet reactivity to collagen. Blood. 105, 186–191.
Chin D., Means A. 2000. Calmodulin: A prototypical calcium sensor. Trends Cell Biol. 10, 322–328.
Gilio K., van Kruchten R., Braun A., Berna-Erro A., Feijge M., Stegner D., van der Meijden P., Kuijpers M., Varga-Szabo D., Heemskerk J., Nieswandt B. 2010. Roles of platelet STIM1 and orai1 in glycoprotein VI- and thrombin-dependent procoagulant activity and thrombus formation. J. Biol. Chem. 285, 23629–23638.
Gilio K., Munnix I., Mangin P., Cosemans J., Feijge M., van der Meijden P., Olieslagers S., Chrzanowska-Wodnicka M., Lillian R., Schoenwaelder S., Koyasu S., Sage S., Jackson S., Heemskerk J. 2009. Non-redundant roles of phosphoinositide 3-kinase isoforms alpha and beta in glycoprotein VI-induced platelet signaling and thrombus formation. J. Biol. Chem. 284, 33750–33762.
Hussain J., Mahaut-Smith M. 1999. Reversible and irreversible intracellular Ca2+ spiking in single isolated human platelets. J. Physiol. 514, 713–718.
Heemskerk J., Vuist W., Feijge M., Reutelingsperger C., Lindhout T. 1997. Collagen but not fibrinogen surfaces induce bleb formation, exposure of phosphatidylserine, and procoagulant activity of adherent platelets: Evidence for regulation by protein tyrosine kinase-dependent Ca2+ responses. Blood. 90, 2615–2625.
Bergmeier W., Oh-Hora M., McCarl C., Roden R., Bray P., Feske S. 2009. R93W mutation in Orai1 causes impaired calcium influx in platelets. Blood. 113, 675–678.
Jung S., Moroi M., Soejima K., Nakagaki T., Miura Y., Berndt M., Gardiner E., Howes J., Pugh N., Bihan D., Watson S. 2012. Constitutive dimerization of glycoprotein VI (GPVI) in resting platelets is essential for binding to collagen and activation in flowing blood. J. Biol. Chem. 287, 30000–30013.
Jung S., Tsuji K., Moroi M. 2009. Glycoprotein (GP) VI dimer as a major collagen-binding site of native platelets: Direct evidence obtained with dimeric GPVI-specific Fabs. J. Thromb. Haemost. 7, 1347–1355.
Lecut C., Arocas V., Ulrichts H., Elbaz A., Villeval J., Lacapère J., Deckmyn H., Jandrot-Perrus M. 2004. Identification of residues within human glycoprotein VI involved in the binding to collagen: Evidence for the existence of distinct binding sites. J. Biol. Chem. 279, 52293–52299.
Gardiner E., Karunakaran D., Arthur J., Mu F., Powell M., Baker R., Hogarth P., Kahn M., Andrews R., Berndt M. 2008. Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: De-ITAM-izing FcgammaRIIa. Blood. 111, 165–174.
Al-Tamimi M., Grigoriadis G., Tran H., Paul E., Servadei P., Berndt M., Gardiner E., Andrews R. 2011. Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa. Blood. 117, 3912–3920.
Al-Tamimi M., Tan C., Qiao J., Pennings G., Javadzadegan A., Yong A., Arthur J., Davis A., Jing J., Mu F.-T., Hamilton J. 2012. Pathologic shear triggers shedding of vascular receptors: A novel mechanism for down-regulation of platelet glycoprotein VI in stenosed coronary vessels. Blood. 119, 4311–4320.
Al-Tamimi M., Arthur J. 2012. Focusing on plasma glycoprotein VI. J. Thromb. Haemost. 108, 648–655.
Rabie T., Varga-Szabo D., Bender M., Pozgaj R., Lanza F., Saito T., Watson S., Nieswandt B. 2007. Diverging signaling events control the pathway of GPVI down-regulation in vivo. Blood. 110, 529–535.
Gardiner E., Karunakaran D., Shen Y., Arthur J., Andrews R., Berndt M., 2007. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J. Thromb. Haemost. 5, 1530–1537.
Arthur J., Qiao J., Shen Y., Davis A., Dunne E., Berndt M., Gardiner E., Andrews R. 2012. ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and Syk-independent pathways. J. Thromb. Haemost. 10, 1133–1141.
Walsh T., Berndt M., Carrim N., Cowman J., Kenny D., Metharom P. 2014. The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation. Redox Biol. 2, 178–186.
Arthur J., Gardiner E., Kenny D., Andrews R., Berndt M. 2009. Platelet receptor redox regulation. Platelets. 19, 1–8.
Freedman J. 2008. Oxidative stress and platelets. Arterioscler. Thromb. Vasc. Biol. 28, 11–16.
Arthur J., Shen Y., Gardiner E., Coleman L., Murphy D., Kenny D., Andrews R., Berndt M. 2011. TNF receptor-associated factor 4 (TRAF4) is a novel binding partner of glycoprotein Ib and glycoprotein VI in human platelets. J. Thromb. Haemost. 9, 163–172.
Berndt M., Shen Y. 2001. The vascular biology of the glycoprotein Ib-IX-V complex. Thromb. and Haemost. 86, 178–188.
Bigalke B., Stellos K., Geisler T., Kremmer E., Seizer P., May A., Lindemann S., Gawaz M. 2011. Glycoprotein VI for diagnosis of acute coronary syndrome when ECG is ambiguous. Int. J. Cardiol. 149, 164–168.
Dütting S., Bender M., Nieswandt B. 2012. Platelet GPVI: A target for antithrombotic therapy?! Trends Pharmacol. Sci. 33, 583–590.
Yakimenko A., Verholomova F., Kotova Y., Ataullakhanov F., Panteleev M. 2012. Identification of different proaggregatory abilities of activated platelet subpopulations. Biophys. J. 102, 2261–2269.
Abaeva A., Canault M., Kotova Y., Obydennyy S., Yakimenko A., Podoplelova N., Kolyadko V., Chambost H., Mazurov A., Ataullakhanov F., Nurden A. 2013. Procoagulant platelets form an alpha-granule protein-covered “cap” on their surface that promotes their attachment to aggregates. J. Biol. Chem. 288, 29621–29632.
Artemenko E., Yakimenko A., Pichugin A., Ataullakhanov F., Panteleev M. 2016. Calpain-controlled detachment of major glycoproteins from the cytoskeleton regulates adhesive properties of activated phosphatidyl-serine-positive platelets. Biochem. J. 473, 435–448.
Agbani E., van den Bosch M., Brown E., Williams C., Mattheij N., Cosemans J., Collins P., Heemskerk J., Hers I., Poole A. 2015. Coordinated membrane ballooning and procoagulant spreading in human platelets. Circulation. 132, 1414–1424.
Choo H., Saafir T., Mkumba L., Wagner M., Jobe S. 2012. Mitochondrial calcium and reactive oxygen species regulate agonist-initiated platelet phosphatidyl-serine exposure. Arterioscler. Thromb. Vasc. Biol. 32, 2946–2955.
Jobe S., Wilson K., Leo L., Raimondi A., Molkentin J., Lentz S., Di Paola J. 2008. Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis. Blood. 111, 1257–1265.
Stalker T., Traxler E., Wu J., Wannemacher K., Cermignano S., Voronov R., Diamond S., Brass L. 2013. Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network. Blood. 121, 1875–1885.
Doggett T., Girdhar G., Lawshe A., Miller J., Laurenzi I., Diamond S., Diacovo T. 2003. Alterations in the intrinsic properties of the GPIb-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val. Blood. 102, 152–160.
Kumar R., Dong J., Thaggard J., Cruz M., López J., McIntire L. 2003. Kinetics of GPIbalpha-vWF-A1 tether bond under flow: Effect of GPIbalpha mutations on the association and dissociation rates. Biophys. J. 85, 4099–4109.
ACKNOWLEDGMENTS
The work was supported by the Russian Foundation for Basic Research (project nos. 16-04-01163 and 16-31-60061-mol_a_dk), by the grants of the President of Russian Federation (project nos. MK-2706.2017.4 and MD-229.2017.4), and by the scholarship grant of the President of Russian Federation (project no. SP-2427.2015.4).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no conflict of interest. This article does not contain any studies involving animals or human participants performed by any of the authors.
Additional information
Translated by E. Puchkov
Rights and permissions
About this article
Cite this article
Sveshnikova, A.N., Belyaev, A.V., Panteleev, M.A. et al. The Role of Transmembrane Glycoproteins, Integrins and Serpentines in Platelet Adhesion and Activation. Biochem. Moscow Suppl. Ser. A 12, 315–326 (2018). https://doi.org/10.1134/S1990747818050070
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990747818050070